Here are what the editors at HealthDay consider to be the most important developments in Ophthalmology for January 2017. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
BMSC-Derived Exosomes Promote Retinal Ganglion Cell Survival
TUESDAY, Jan. 31, 2017 (HealthDay News) — Bone marrow-derived mesenchymal stem cell (BMSC)-derived exosomes promote retinal ganglion cell (RGC) survival, according to a study published online Jan. 26 in Stem Cells Translational Medicine.
Very Low LDL-C Levels Well Tolerated With Alirocumab
MONDAY, Jan. 30, 2017 (HealthDay News) — For patients treated with alirocumab, very low low-density lipoprotein cholesterol (LDL-C) levels are not associated with increased treatment-emergent adverse event rates, according to research published in the Feb. 7 issue of the Journal of the American College of Cardiology.
Inconsistency Noted in Ocular Symptom Reporting
MONDAY, Jan. 30, 2017 (HealthDay News) — Patient self-report of symptoms on an Eye Symptom Questionnaire (ESQ) is frequently inconsistent with documentation in the electronic medical record (EMR), according to a study published online Jan. 26 in JAMA Ophthalmology.
Most PCPs Oppose Complete Repeal of the Affordable Care Act
THURSDAY, Jan. 26, 2017 (HealthDay News) — A majority of primary care doctors oppose full repeal of the Affordable Care Act, according to a perspective piece published online Jan. 25 in the New England Journal of Medicine.
Strategies Presented for Addressing Uncompensated Time
THURSDAY, Jan. 26, 2017 (HealthDay News) — Strategies can be employed to help physicians deal with the increasing burden of uncompensated tasks, according to an article published in Medical Economics.
‘Opt Out’ Doesn’t Increase Access to Anesthesia Care
WEDNESDAY, Jan. 25, 2017 (HealthDay News) — The “opt out” rule, which allows U.S. states to opt out of the regulations requiring physician supervision of nurse anesthetists has not increased access to anesthesia care for certain common procedures, according to a study published online Jan. 19 in Anesthesiology.
Obesity Underrepresented in Medical Licensing Exams
FRIDAY, Jan. 20, 2017 (HealthDay News) — The most important concepts of obesity prevention and treatment are not adequately represented on the U.S. Medical Licensing Examination (USMLE) Step examinations, according to a study published recently in Teaching and Learning in Medicine.
Iatrogenic Cushing’s Syndrome Described in 9-Year-Old Girl
FRIDAY, Jan. 20, 2017 (HealthDay News) — In a case report published online Jan. 19 in Pediatrics, iatrogenic Cushing’s syndrome (CS) is described in a 9-year-old girl who received topical ocular glucocorticoid (GC) treatment for bilateral iridocyclitis.
Experimental Drug May Simplify Macular Degeneration Treatment
THURSDAY, Jan. 19, 2017 (HealthDay News) — An experimental drug, AXT107, may one day make treatment simpler for patients with age-related macular degeneration, according to research published in the Jan. 18 issue of Science Translational Medicine.
Bariatric Sx May Help Prevent Incident Diabetic Retinopathy
WEDNESDAY, Jan. 18, 2017 (HealthDay News) — There are fewer cases of incident diabetic retinopathy among obese patients with type 2 diabetes undergoing bariatric surgery compared with medical treatment, according to a review and meta-analysis published online Jan. 13 in Obesity Reviews.
Physician Excess Charges Create Financial Burden for Patients
TUESDAY, Jan. 17, 2017 (HealthDay News) — Many doctors bill their private-paying patients two, three, even six times more than what Medicare pays for the same services, according to a research letter published in the Jan. 17 issue of the Journal of the American Medical Association.
Modest Links for Systemic Medication Use, IOP in Glaucoma
FRIDAY, Jan. 13, 2017 (HealthDay News) — Some systemic medication has a modest effect on intraocular pressure (IOP) among Asian patients with glaucoma, according to research published online Jan. 12 in JAMA Ophthalmology.
Excessive FDA Regulation Driving High Drug Prices
WEDNESDAY, Jan. 11, 2017 (HealthDay News) — The excessive regulatory regime at the U.S. Food and Drug Administration is an important driver of high drug prices, and should be curbed to introduce more competition and lower prices, according to a report published online Jan. 5 by the National Center for Policy Analysis.
Major Increase in U.S. Glaucoma Cases Expected by 2030
FRIDAY, Jan. 6, 2017 (HealthDay News) — Glaucoma affects more than three million Americans, but that number is expected to surge to more than four million by 2030, according to the Glaucoma Research Foundation.
Diabetes Linked to Increased Incidence of Conjunctivitis
FRIDAY, Jan. 6, 2017 (HealthDay News) — Diabetes is associated with increased incidence of conjunctivitis, according to a study published online Dec. 29 in Diabetes Care.
Copyright © 2017 ScoutNews, LLC. All rights reserved.